Clinical Trials Logo

Stress Disorders clinical trials

View clinical trials related to Stress Disorders.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT01216982 Active, not recruiting - Depression Clinical Trials

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders

Start date: November 2010
Phase: Phase 2
Study type: Interventional

Stress-related disorders are among the most prevalent and expensive medical consequences of participation in military operations. Omega-3 fatty acids EPA/DHA derived from fish oil are known to benefit both neuronal development in the young, and cognition and mood in various populations. It is possible that soldiers receiving Omega-3 EPA/DHA will exhibit significantly higher cognitive performance, better affect/mood state, and less combat stress symptomatology compared to the placebo after 12 weeks of supplementation. A goal would be to reduce the prevalence of combat stress injuries in military personnel.